天津药物研究院药业

Tianjin Institute of Pharmaceutical Research Pharmaceutical (TJIPR Pharmaceutical) is a prominent Chinese pharmaceutical company that serves as the industrialization base for the Tianjin Institute of Pharmaceutical Research. The company specializes in the research, development, and large-scale manufacturing of chemical drugs and modern Chinese medicines. Its extensive product portfolio covers critical therapeutic areas including cardiovascular health, the central nervous system, and anti-infective treatments. TJIPR Pharmaceutical operates multiple GMP-certified production lines for various dosage forms such as tablets, capsules, and injections. Since its restructuring and integration into the China Merchants Group in 2018, the company has focused on accelerating the commercialization of innovative therapies and high-end generics. It remains a key player in the Chinese domestic market, leveraging decades of institutional R&D heritage.